Navigation Links
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Results
Date:2/16/2010

class="xn-money">$3.6 million for the fourth quarter of 2008.  The increase in R&D expenses in the fourth quarter of 2009 relative to the third quarter of 2009 is primarily due to 2009 employee bonus expense.  The decrease in R&D expenses in the fourth quarter of 2009 relative to the fourth quarter of 2008 is primarily due to the regulatory consulting fees relating to Fanapt™ accrued in the fourth quarter of 2008.  For the full year of 2009, total R&D expenses were $13.9 million, compared to $23.9 million for 2008.  Lower R&D expenses resulted from the lower clinical trial costs and related manufacturing costs incurred in 2009.  
  • General and administrative (G&A) expenses of $9.2 million for the fourth quarter of 2009 consisted primarily of $1.3 million of salaries and benefits and $1.9 million of non-cash stock based compensation costs for G&A personnel, as well as $1.2 million of legal fees and $3.7 million of consulting fees and financial advisors fees primarily relating to the transaction with Novartis, and $0.2 million of insurance costs.  This compares to $5.3 million for the third quarter of 2009 and $4.1 million for the fourth quarter of 2008.  The increase in G&A expenses in the fourth quarter of 2009 relative to the third quarter of 2009 and the fourth quarter of 2008 is primarily due to an increase in legal and consulting fees and financial advisor fees accrued in the fourth quarter of 2009 relating to the transaction with Novartis.  For the full year of 2009, total G&A expenses were $23.7 millio
    '/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Vanda Pharmaceuticals Reports Second Quarter 2009 Results
2. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
3. Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting
4. Vanda Pharmaceuticals Reports First Quarter 2009 Results
5. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results
6. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
7. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
8. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
9. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
10. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
11. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... Dec. 15, 2014  GlassesOff Inc. (OTCBB: GLSO) announced ... as an independent director of the Company,s Board of ... and served as its CEO until its acquisition by ... $240 million transaction. Recognized as the inventor of the ... AeroScout provided Wi-Fi -based RFID solutions focused on improving ...
(Date:12/13/2014)... 2014 Clarassance, a privately held clinical-stage ... name: Therabron Therapeutics , Inc. The new name ... type of structure in the lungs similar to branches ... develop novel protein therapeutics for the treatment of respiratory ... change the name to mark the company's escalation into ...
(Date:12/13/2014)... QuickSTAT is making significant investments in ... capabilities, and is delighted to announce the opening of ... Life Science clients in the region. , QuickSTAT France, ... will provide 24/7 transportation and logistics services, as well ... specimens, API, following IATA rules and EU GDP guidelines. ...
(Date:12/12/2014)... 11, 2014 InSphero AG, the world’s ... testing, announced today that data presented recently by Genentech ... as a more predictive model system for assessment of ... 2nd Annual Functional Analysis and Screening Technologies (FAST) ... response of InSphero’s 3D InSight™ Human Liver Microtissues ...
Breaking Biology Technology:AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2Quick Opens Office in France to Serve Life Science Community In France and Neighboring French-Speaking Countries 2Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 2Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 3
... Exchange Symbol: MS, EDMONTON, March 24 /PRNewswire-FirstCall/ - ... treatment of multiple sclerosis (MS), today,announced that Mr. Kevin ... Leaders in the Biotech Industry" Conference in New York., ... 2:00pm (Eastern Time), WHERE: The Millennium Broadway ...
... CLARA, Calif., March 24 Finesse Solutions, LLC, ... sciences process,applications, announces the release of TruFluor(TM), a ... in Philadelphia on March,26, 2008., The TruFluor(TM) ... consisting of a disposable sheath, an optical reader,and ...
... 21 Martek Biosciences,(Nasdaq: MATK ) announced today ... Martek,s patented, vegetarian form of DHA,omega-3 for brain, eye ... of 100 mg per gram of life,sDHA and contains ... and supplement applications where,allergens and labeling are concerns., ...
Cached Biology Technology:BioMS Medical to present at BioCentury Conference 2Finesse Introduces TruFluor(TM) DO, a Single-Use Optical Dissolved Oxygen Sensor and Transmitter 2Martek's life'sDHA(TM) Now Available in Protein-free Powder 2Martek's life'sDHA(TM) Now Available in Protein-free Powder 3
(Date:12/10/2014)... You,ve been here before: you desperately need to ... password, site key or the answer to your secret question. ... Today, Hoyos Labs , a digital ... finally put an end to the frustration that comes with ... 1U leverages a user,s smartphone to acquire his or her ...
(Date:12/10/2014)... DIEGO , Dec. 9, 2014 CIE ... collaboration catalyst that provides the connective tissue that enhances ... enabling them to easily share client-level information; earned a ... to expand to organizations serving seniors aging in community ... Diego" partner on December 11 th 4-6p. ...
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... compound showed significant success in controlling the infectivity and spread ... has been no medicine approved to treat such viruses, which ... immune systems have been weakened. The compound, known ... vast majority of cells in cultures when it was administered ...
... the body measures carbon dioxide and suggests that far from ... role as a biological signalling molecule. Researchers led by ... the University of Warwick have shown that the body senses ... as a receptor for the gas. Connexin 26 is better ...
... 13, 2013) Scientists from the New York Stem ... Center (CUMC) have used stem cells created from the ... syndrometo elucidate an important biochemical pathway for beta-cell failure ... were published today in Diabetes . ...
Cached Biology News:Compound stymies polyomaviruses in lab tests 2Compound stymies polyomaviruses in lab tests 3Carbon dioxide's new-found signalling role could be applied to blood flow, birth and deafness 2Human stem cells used to elucidate mechanisms of beta-cell failure in diabetes 2Human stem cells used to elucidate mechanisms of beta-cell failure in diabetes 3
... phase reagent for Virus ... & unique water insoluble ... detergents and chaotropes; Engineered ... non-envelop viruses while preserving ...
Handles samples from from 75l to 150l...
PKA Sampler Kit 10 mu g each...
Chaperone Sampler Kit 10 mu g each...
Biology Products: